Visit MEDViResearched against FDA labeling, published clinical-trial data (STEP-1 / SURMOUNT-1), and MEDVi's live pages, not a paid placement.
MEDVi Review (2026): Compounded GLP-1 with Oral + Injectable
MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
MEDVi is the best option for needle-averse users who want a clear pathway from oral to injectable GLP-1 treatment. Full verdict ↓
Clinical evidence: 20.9% average body-weight reduction at 72 weeks in SURMOUNT-1 (NEJM, 2022). Individual results vary; compounded GLP-1s are not FDA-approved.
Summarize this article with
MEDVi scores 7.7/10 in our independent review, starting at $179/mo for brand-name and compounded GLP-1 medications. MEDVi is one of the few platforms offering both oral tablets and injectable compounded semaglutide, backed by a 4.4/5 Trustpilot rating across roughly 11,000 reviews.
What makes it different: The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients.
At a glance
- Needle-averse users who want to start with oral and potentially transition to injectable
- Patients with GI sensitivity who want micro-dosing below standard protocols
- Users who value a sleek digital experience with progress tracking
- Users who want brand-name FDA-approved Wegovy or Zepbound (MEDVi added Ozempic in 2026 but not Wegovy/Zepbound)
- Those who need insurance billing
- Patients who want a long, established track record (MEDVi launched 2023)
MEDVi Pros and Cons
What We Like
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
What Could Be Better
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
What it costs
Headline pricing, full-year math, and how MEDVi compares to the closest alternatives.
Quick facts
All pricing tiers
Injectable Semaglutide (first month)
$179/moIntroductory first-month rate for injectable compounded semaglutide
Injectable Semaglutide (ongoing)
$299/moOngoing monthly rate for injectable compounded semaglutide
Oral Semaglutide Tablets (first month)
$249/moIntroductory first-month rate for oral compounded semaglutide
Oral Semaglutide Tablets (ongoing)
$369/moOngoing monthly rate for oral compounded semaglutide
Compounded Tirzepatide (first month)
$279/moIntroductory first-month rate for compounded tirzepatide (injectable or oral)
Compounded Tirzepatide (ongoing)
$399/moOngoing monthly rate for compounded tirzepatide
Brand-name Ozempic
$1999/moFDA-approved Ozempic cash price, added in 2026
Cancellation policy: Cancel anytime with 7-day notice
What third-party review aggregators say about MEDVi. Cards show the verified primary metric only, “Not found” means no public profile surfaced in our verification pass.
MEDVi (GLP-1 telehealth, real Trustpilot profile at medvi.org) carries a high 4.4/5 TrustScore across ~11,000+ reviews, with praise for fast approval and responsive support, but its BBB profile is an unaccredited F, and recurring complaints across platforms center on billing confusion and slow refunds (ConsumerAffairs sits lower at ~3.6/5).
Reddit: No substantial dedicated MEDVi Reddit threads surfaced; aggregated third-party sentiment praises fast approval and responsive support but flags recurring billing and refund-delay complaints.
Trustpilot: Verified June 19, 2026, external-reviews verification pass.
Health Assessment + Preference Selection
Complete your health profile and indicate your preference for oral tablets or injectable semaglutide. MEDVi's intake specifically addresses needle concerns and GI sensitivity.
Provider Consultation + Micro-Dose Option
Your provider reviews your profile and can start you at micro-doses below standard protocols if you're concerned about side effects. Oral or injectable, your choice.
Treatment + Progress Tracking
Medication ships free. Track your weight, side effects, and milestones through MEDVi's patient portal. Transition from oral to injectable anytime.
Medications available
Ready to check MEDVi's pricing for yourself?
Visit MEDViSix trust signals, how we checked them, and what's been updated since the last review.
What the doctors say about GLP-1 medications
Independent, sourced clinical context on the medication class, not a comment on this provider.
“Our research highlights the safety and the potential for GLP-1 receptor agonists to reduce the risk of acute pancreatitis recurrence in individuals with obesity and type 2 diabetes, challenging previous concerns and offering new hope for effective disease management.”
“More options for people with these challenging diseases will be very helpful, particularly if the new oral tablet medicines are priced reasonably.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.
Common questions
Questions readers ask about MEDVi, similar providers to compare, and quick tools.
Frequently Asked Questions
How effective is oral compounded semaglutide vs. injectable?+
What is micro-dosing and how does it work?+
Can I switch from oral to injectable mid-treatment?+
Does MEDVi offer tirzepatide?+
People also compare MEDVi
Alternatives to MEDVi
Similar providers by type, price, and features
Still comparing?
See how MEDVi compares to other GLP-1 programs.
Ready to get started with MEDVi?
Starting at $179/mo. See if you qualify today.
Visit MEDViOr jump to a specific program